Family Cancer History Raises Colorectal Cancer Risk in IBD Patients

A new study reveals that individuals with inflammatory bowel disease (IBD) face a substantially increased risk of developing colorectal cancer when multiple close relatives have been diagnosed with the condition. Published in the journal *Gastroenterology*, the research highlights a pronounced correlation between familial cancer burden and disease progression in IBD patients, suggesting that the number of affected relatives may be a more accurate risk indicator than previously utilized in clinical practice.

Conducted by researchers at Karolinska Institutet, the Swedish registry-based analysis evaluated large-scale population data to track cancer incidence among IBD patients with varying family histories. The findings demonstrate that colorectal cancer risk rises significantly as the count of affected first-degree relatives increases, pointing to a cumulative interplay of genetic predisposition and chronic intestinal inflammation. By leveraging comprehensive national health records, the study provides robust epidemiological evidence that family cancer clustering meaningfully influences disease trajectories in this patient population.

The results prompt a reevaluation of current surveillance protocols, which typically consider the presence of a single affected relative rather than the total number of family cases. Researchers suggest that updated screening guidelines could improve risk stratification by incorporating detailed familial cancer histories, potentially enabling more targeted and timely monitoring for high-risk IBD patients. As clinical practices adapt to